Micafungin
Micafungin, Mycamine (micafungin) is a small molecule pharmaceutical. Micafungin was first approved as Micafungin on 2005-03-16. It is used to treat candidemia and mycoses in the USA. It has been approved in Europe to treat candidiasis. Mycamine's patent is valid until 2021-01-08 (FDA).
| Trade Name | Mycamine |
|---|---|
| Common Name | Micafungin |
| Indication | candidemia, candidiasis, mycoses |
| Drug Class | Antifungal antibiotics (undefined group) |
